Journal of Clinical Medicine (Sep 2023)

Transcutaneous CO<sub>2</sub> Monitoring in Extremely Low Birth Weight Premature Infants

  • Liron Borenstein-Levin,
  • Noa Avishay,
  • Orit Soffer,
  • Shmuel Arnon,
  • Arieh Riskin,
  • Gil Dinur,
  • Karen Lavie-Nevo,
  • Ayala Gover,
  • Amir Kugelman,
  • Ori Hochwald

DOI
https://doi.org/10.3390/jcm12175757
Journal volume & issue
Vol. 12, no. 17
p. 5757

Abstract

Read online

Extremely low birth weight (ELBW) premature infants are particularly susceptible to hypocarbia and hypercarbia, which are associated with brain and lung morbidities. Transcutaneous CO2 (TcCO2) monitoring allows for continuous non-invasive CO2 monitoring during invasive and non-invasive ventilation and is becoming more popular in the NICU. We aimed to evaluate the correlation and agreement between CO2 levels measured by a TcCO2 monitor and blood gas CO2 (bgCO2) among ELBW infants. This was a prospective observational multicenter study. All infants 2 monitor, if available. For each bgCO2 measured, a simultaneous TcCO2 measurement was documented. In total, 1828 pairs of TcCO2–bgCO2 values of 94 infants were collected, with a median (IQR) gestational age of 26.4 (26.0, 28.3) weeks and birth weight of 800 (702, 900) g. A moderate correlation (Pearson: r = 0.64) and good agreement (bias (95% limits of agreement)):(2.9 [−11.8, 17.6] mmHg) were found between the TcCO2 and bgCO2 values in the 25–70 mmHg TcCO2 range. The correlation between the TcCO2 and bgCO2 trends was moderate. CO2 measurements by TcCO2 are in good agreement (bias 2 among premature infants 2 as a complementary tool to blood gas sampling, to assess CO2 levels and trends in individual patients.

Keywords